Crinetics Pharmaceuticals IncNASDAQ:CRNX
- LAST PRICE45.3700
- TODAY'S CHANGE (%)-0.4400 (-0.9605%)
- Bid / Lots44.9000/ 1
- Ask / Lots48.0000/ 1
- Open / Previous Close46.1300 / 45.8100
- Day Range
- 52 Week Range
- Volume573,076
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CRNX |
|---|---|---|
| 09:32 ET | 2776 | 45.88 |
| 09:34 ET | 100 | 45.88 |
| 09:36 ET | 100 | 46.13 |
| 09:38 ET | 350 | 45.96 |
| 09:39 ET | 1300 | 45.97 |
| 09:43 ET | 200 | 46.03 |
| 09:48 ET | 300 | 45.84 |
| 09:52 ET | 100 | 45.995 |
| 09:54 ET | 1141 | 45.86 |
| 09:56 ET | 400 | 45.87 |
| 09:57 ET | 4097 | 45.81 |
| 10:01 ET | 860 | 45.83 |
| 10:03 ET | 3869 | 46.05 |
| 10:06 ET | 1147 | 45.89 |
| 10:08 ET | 1165 | 45.96 |
| 10:10 ET | 500 | 46 |
| 10:15 ET | 1709 | 46.12 |
| 10:17 ET | 100 | 46.1315 |
| 10:19 ET | 1250 | 46.31 |
| 10:21 ET | 1100 | 46.2964 |
| 10:26 ET | 649 | 46.28 |
| 10:28 ET | 2000 | 46.49 |
| 10:30 ET | 200 | 46.47 |
| 10:32 ET | 2961 | 46.5 |
| 10:33 ET | 500 | 46.42 |
| 10:37 ET | 214 | 46.46 |
| 10:39 ET | 1300 | 46.26 |
| 10:42 ET | 300 | 46.22 |
| 10:44 ET | 100 | 46.19 |
| 10:46 ET | 100 | 46.235 |
| 10:48 ET | 1500 | 46.21 |
| 10:50 ET | 200 | 46.21 |
| 10:51 ET | 100 | 46.17 |
| 10:55 ET | 2072 | 45.91 |
| 10:57 ET | 518 | 45.9 |
| 11:02 ET | 300 | 45.82 |
| 11:04 ET | 1100 | 45.86 |
| 11:06 ET | 1936 | 45.86 |
| 11:08 ET | 200 | 45.92 |
| 11:09 ET | 200 | 45.84 |
| 11:11 ET | 1661 | 45.81 |
| 11:13 ET | 2103 | 45.91 |
| 11:18 ET | 662 | 45.9092 |
| 11:20 ET | 550 | 45.88 |
| 11:22 ET | 200 | 45.95 |
| 11:24 ET | 1700 | 45.94 |
| 11:27 ET | 200 | 45.9 |
| 11:31 ET | 200 | 45.9 |
| 11:33 ET | 100 | 45.895 |
| 11:38 ET | 114 | 45.9 |
| 11:40 ET | 1536 | 45.865 |
| 11:42 ET | 2263 | 46 |
| 11:44 ET | 300 | 45.98 |
| 11:45 ET | 200 | 45.93 |
| 11:49 ET | 850 | 46.01 |
| 11:51 ET | 400 | 46.08 |
| 11:54 ET | 100 | 46.04 |
| 11:56 ET | 200 | 46.09 |
| 11:58 ET | 100 | 46.1 |
| 12:00 ET | 300 | 46.07 |
| 12:02 ET | 300 | 46.1 |
| 12:03 ET | 837 | 46.09 |
| 12:05 ET | 1900 | 46.01 |
| 12:07 ET | 1139 | 46.22 |
| 12:18 ET | 600 | 46.16 |
| 12:20 ET | 100 | 46.11 |
| 12:21 ET | 300 | 46.11 |
| 12:25 ET | 400 | 46.05 |
| 12:30 ET | 236 | 46.075 |
| 12:32 ET | 600 | 45.96 |
| 12:34 ET | 200 | 45.925 |
| 12:36 ET | 400 | 46 |
| 12:38 ET | 2308 | 45.875 |
| 12:39 ET | 2746 | 46.03 |
| 12:48 ET | 1318 | 46.07 |
| 12:50 ET | 400 | 46.06 |
| 12:52 ET | 450 | 46.035 |
| 12:54 ET | 100 | 46.04 |
| 12:56 ET | 300 | 46.01 |
| 12:57 ET | 100 | 46.03 |
| 12:59 ET | 1100 | 46.13 |
| 01:01 ET | 200 | 46.07 |
| 01:06 ET | 200 | 46.04 |
| 01:08 ET | 500 | 46.06 |
| 01:10 ET | 1000 | 46.17 |
| 01:12 ET | 703 | 46.205 |
| 01:14 ET | 1055 | 46.21 |
| 01:15 ET | 400 | 46.2475 |
| 01:19 ET | 100 | 46.27 |
| 01:21 ET | 500 | 46.2501 |
| 01:26 ET | 1400 | 46.22 |
| 01:28 ET | 1510 | 46.37 |
| 01:33 ET | 1387 | 46.34 |
| 01:37 ET | 2200 | 46.21 |
| 01:39 ET | 520 | 46.27 |
| 01:42 ET | 1542 | 46.16 |
| 01:44 ET | 433 | 46.1 |
| 01:46 ET | 151 | 46.155 |
| 01:48 ET | 200 | 46.12 |
| 01:51 ET | 230 | 46.05 |
| 01:53 ET | 100 | 46.1375 |
| 01:55 ET | 100 | 46.07 |
| 01:57 ET | 500 | 46.085 |
| 02:04 ET | 7362 | 46.08 |
| 02:08 ET | 1100 | 46.01 |
| 02:09 ET | 295 | 45.9904 |
| 02:11 ET | 538 | 45.98 |
| 02:13 ET | 1000 | 45.91 |
| 02:15 ET | 200 | 45.96 |
| 02:18 ET | 3634 | 45.975 |
| 02:24 ET | 14072 | 45.975 |
| 02:26 ET | 551 | 45.96 |
| 02:27 ET | 2007 | 45.905 |
| 02:29 ET | 1600 | 45.89 |
| 02:31 ET | 100 | 45.9 |
| 02:36 ET | 1176 | 45.83 |
| 02:38 ET | 100 | 45.81 |
| 02:40 ET | 7721 | 45.8 |
| 02:42 ET | 2400 | 45.865 |
| 02:44 ET | 900 | 45.87 |
| 02:45 ET | 727 | 45.94 |
| 02:47 ET | 300 | 45.94 |
| 02:49 ET | 900 | 45.88 |
| 02:51 ET | 800 | 45.96 |
| 02:54 ET | 594 | 45.93 |
| 02:56 ET | 2612 | 45.83 |
| 02:58 ET | 600 | 45.84 |
| 03:00 ET | 475 | 45.845 |
| 03:02 ET | 1923 | 45.935 |
| 03:03 ET | 1302 | 45.96 |
| 03:05 ET | 1200 | 46.06 |
| 03:07 ET | 700 | 46.075 |
| 03:09 ET | 7756 | 45.96 |
| 03:14 ET | 500 | 45.86 |
| 03:16 ET | 1508 | 45.68 |
| 03:18 ET | 1713 | 45.705 |
| 03:20 ET | 1100 | 45.77 |
| 03:21 ET | 201 | 45.63 |
| 03:23 ET | 700 | 45.5275 |
| 03:25 ET | 1236 | 45.48 |
| 03:27 ET | 900 | 45.495 |
| 03:30 ET | 1050 | 45.46 |
| 03:32 ET | 2481 | 45.49 |
| 03:34 ET | 447 | 45.43 |
| 03:36 ET | 500 | 45.33 |
| 03:38 ET | 1753 | 45.32 |
| 03:39 ET | 13197 | 45.37 |
| 03:41 ET | 1003 | 45.32 |
| 03:43 ET | 2145 | 45.28 |
| 03:45 ET | 1300 | 45.28 |
| 03:48 ET | 3959 | 45.42 |
| 03:50 ET | 2100 | 45.27 |
| 03:52 ET | 12198 | 45.22 |
| 03:54 ET | 9553 | 45.2 |
| 03:56 ET | 15204 | 45.335 |
| 03:57 ET | 29849 | 45.25 |
| 03:59 ET | 115251 | 45.37 |
Today
Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affairs, from 3 hours ago by Dow Jones
3 hours ago by Dow JonesPress Release: Crinetics Pharmaceuticals Appoints Robert M. Cuddihy, M.D., as Senior Vice President of Medical Affairs, from 3 hours ago by Dow Jones
3 hours ago by Dow Jones
May 23, 2024
DJ Crinetics Pharmaceuticals Is Maintained at Outperform by Baird, from 12:48PM ET on Thursday May 23, 2024 by Dow Jones
12:48PM ET on Thursday May 23, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Is Maintained at Overweight by Morgan Stanley, from 11:33AM ET on Thursday May 23, 2024 by Dow Jones
11:33AM ET on Thursday May 23, 2024 by Dow JonesDJ Crinetics Pharmaceuticals Price Target Maintained With a $60.00/Share by HC Wainwright & Co., from 7:25AM ET on Thursday May 23, 2024 by Dow Jones
7:25AM ET on Thursday May 23, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Crinetics Pharmaceuticals Inc | 3.6B | -12.0x | --- |
Vitaspring Biomedical Co. Ltd | 3.1B | 3,311.3x | --- |
SpringWorks Therapeutics Inc | 3.0B | -8.3x | --- |
Dyne Therapeutics Inc | 3.0B | -7.9x | --- |
Nuvalent Inc | 4.3B | -27.6x | --- |
Merus NV | 3.2B | -21.0x | --- |
Company Information
Crinetics Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its Paltusotine, an investigational, oral somatostatin receptor type 2 (SST2) agonist, is in Phase 3 clinical development for acromegaly and Phase 2 clinical development for carcinoid syndrome associated with neuroendocrine tumors. It has demonstrated pharmacologic proof-of-concept in a Phase 1 clinical study for CRN04894, an investigational, oral ACTH antagonist, that is in Phase 2 clinical studies for the treatment of congenital adrenal hyperplasia and Cushing's disease. Its drug candidates are orally delivered, small molecule new chemical entities resulting from in-house drug discovery efforts, including other programs addressing a variety of endocrine conditions such as hyperparathyroidism, polycystic kidney disease, Graves' disease, thyroid eye disease, diabetes and obesity.
Contact Information
- Headquarters
- 10222 Barnes Canyon Rd Bldg 2SAN DIEGO, CA, United States 92121-2711
- Phone
- 858-450-6464
- Fax
- 302-636-5454
Executives
- Independent Chairman of the Board
- Wendell Wierenga
- President, Chief Executive Officer, Co-Founder, Director
- R. Scott Struthers
- Co-Founder, Chief Scientific Officer
- Stephen Betz
- Chief Financial Officer
- Marc Wilson
- Chief Operating Officer
- Jeff Knight
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.6B |
|---|---|
Revenue (TTM) | $2.0M |
Shares Outstanding | 78.9M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.65 |
EPS | $-3.77 |
Book Value | $7.91 |
P/E Ratio | -12.0x |
Price/Sales (TTM) | 1,830.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -12,571.38% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
